Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Brennan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|June 5, 2014
Pharmacogenetics of second-generation antipsychoticsMark D Brennan
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 10, 2005
Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophreniaMark D Brennan, Jodi Condra
Schizophrenia Research|December 3, 2014
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trialTimothy L Ramsey, Mark D Brennan
Pharmacogenomics|June 24, 2014
Replication of SULT4A1-1 as a pharmacogenetic marker of olanzapine response and evidence of lower weight gain in the high response groupTimothy L Ramsey, Qian Liu, Mark D Brennan
Schizophrenia Research|March 7, 2009
A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility geneYanglong Zhu, Ted Kalbfleisch, Mark D Brennan, et al.
Psychiatric Genetics|August 31, 2007
Evidence for two schizophrenia susceptibility genes on chromosome 22q13Jodi A Condra, Holly Neibergs, Wei Wei, et al.
Pharmacogenomics|August 28, 2012
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE studyQian Liu, Maidar Jamba, Calvin Patrick, et al.
Schizophrenia Research|July 27, 2013
Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE studyTimothy L Ramsey, Qian Liu, Bill W Massey, et al.
Schizophrenia Research|October 1, 2008
Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorderHerbert Y Meltzer, Mark D Brennan, Neil D Woodward, et al.
Schizophrenia Research|April 23, 2017
Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genesJiang Li, Akane Yoshikawa, Mark D Brennan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|June 5, 2014
Pharmacogenetics of second-generation antipsychoticsMark D Brennan
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 10, 2005
Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophreniaMark D Brennan, Jodi Condra
Schizophrenia Research|December 3, 2014
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trialTimothy L Ramsey, Mark D Brennan
Pharmacogenomics|June 24, 2014
Replication of SULT4A1-1 as a pharmacogenetic marker of olanzapine response and evidence of lower weight gain in the high response groupTimothy L Ramsey, Qian Liu, Mark D Brennan
Schizophrenia Research|March 7, 2009
A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility geneYanglong Zhu, Ted Kalbfleisch, Mark D Brennan, et al.
Psychiatric Genetics|August 31, 2007
Evidence for two schizophrenia susceptibility genes on chromosome 22q13Jodi A Condra, Holly Neibergs, Wei Wei, et al.
Pharmacogenomics|August 28, 2012
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE studyQian Liu, Maidar Jamba, Calvin Patrick, et al.
Schizophrenia Research|July 27, 2013
Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE studyTimothy L Ramsey, Qian Liu, Bill W Massey, et al.
Schizophrenia Research|October 1, 2008
Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorderHerbert Y Meltzer, Mark D Brennan, Neil D Woodward, et al.
Schizophrenia Research|April 23, 2017
Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genesJiang Li, Akane Yoshikawa, Mark D Brennan, et al.
Pageof 2